Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
39
37
36
41
36
31
Croissance des revenus (H/H)
8%
3%
-12%
14%
16%
55%
Coût des ventes
27
30
26
23
19
13
Bénéfice brut
12
7
10
17
17
17
Vente, Général et Administration
26
28
34
37
24
10
Recherche et développement
2
2
5
7
4
1
Frais d'exploitation
30
32
41
46
29
13
Autres revenus (charges) non opérationnels
0
0
0
0
0
0
Bénéfice avant impôts
-18
-26
-37
-49
-12
4
Charge d'impôt sur le revenu
0
0
0
-1
-2
1
Bénéfice net
-18
-26
-36
-47
-9
0
Croissance du bénéfice net
-42%
-28%
-23%
422%
--
-100%
Actions en circulation (diluées)
53.51
46.74
31.81
28.08
16.09
27.11
Variation des actions (H-H)
3%
47%
13%
75%
-41%
0%
EPS (dilué)
-0.34
-0.57
-1.15
-1.69
-0.61
0.02
Croissance du EPS
-43%
-51%
-32%
177%
-3,150%
-140%
Flux de trésorerie libre
-10
-13
-26
-55
-28
-2
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
30.76%
18.91%
27.77%
41.46%
47.22%
54.83%
Marge opérationnelle
-43.58%
-64.86%
-86.11%
-68.29%
-33.33%
12.9%
Marge bénéficiaire
-46.15%
-70.27%
-100%
-114.63%
-25%
0%
Marge du flux de trésorerie libre
-25.64%
-35.13%
-72.22%
-134.14%
-77.77%
-6.45%
EBITDA
-11
-18
-26
-25
-10
6
Marge EBITDA
-28.2%
-48.64%
-72.22%
-60.97%
-27.77%
19.35%
D&A pour le résultat opérationnel
6
6
5
3
2
2
EBIT
-17
-24
-31
-28
-12
4
Marge EBIT
-43.58%
-64.86%
-86.11%
-68.29%
-33.33%
12.9%
Taux d'imposition effectif
0%
0%
0%
2.04%
16.66%
25%
Statistiques clés
Clôture préc.
$2
Prix d'ouverture
$2
Plage de la journée
$1.92 - $2.11
Plage de 52 semaines
$1.96 - $10
Volume
40.4K
Volume moyen
203.6K
BPA (TTM)
-0.34
Rendement en dividend
--
Capitalisation boursière
$105.1M
Qu’est-ce que TKNO ?
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.